In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the ...

Rabies is notoriously difficult to treat once symptoms begin, and that challenge starts at the molecular level. Unlike many ...

Prasad’s departure may outline the political limits of medical skepticism in the Republican party, at least when it comes to ...

The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

Although the COVID vaccine does not contain gp145, Dr Krawczyk said it was wrong to suggest it could in any way lead to HIV, ...

An mRNA cancer vaccine triggered strong immune responses and improved treatment outcomes in mice, offering a new approach to ...

Editas' share price has struggled due to clinical setbacks, but recent focus on in-vivo gene editing offers renewed hope and ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

A new mRNA-based vaccine triggers a response from the innate immune system to help arm the body against cancer, a mouse study finds. It's now in early human trials.

School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom ...

University of Geneva researchers led a collaboration for testing different size-exclusion chromatography columns to compare ...